Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-small Cell Carcinoma × binimetinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 17 Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 6 Lung Neoplasms 5 Brain Neoplasms 5 Skin Neoplasms 4 Neoplasms 4 Triple Negative Breast Neoplasms 3 Uveal Melanoma 2 Thyroid Neoplasms 2 Ovarian Neoplasms 2 Leukemia, Hairy Cell 2 Breast Neoplasms 2 Solid Tumors 1 Solid Tumor 1 Soft Tissue Neoplasms 1 Skin Diseases 1 Peripheral Nervous System Neoplasms 1 Pancreatic Neoplasms 1 Non-small Cell Carcinoma 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Multiple Myeloma 1 Lymphoma 1 Lymphatic Metastasis 1 Hematologic Neoplasms 1 Glioma 1 Gastrointestinal Stromal Tumors 1

Interventions

pembrolizumab 1 osimertinib 1 binimetinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03991819 2025-12-05

BiniPembro

University Health Network, Toronto

Phase 1 Recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡